Series C - Bright Peak Therapeutics
Investment Firm
Overview
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Announced Date
Jun 11, 2024
Funding Type
Series C
Highlights
Location
Switzerland, Europe
Social
Investor Lead
N/A
Participant Investors
8
Round Details and Background
Bright Peak Therapeutics raised $90000000 on 2024-06-11 in Series C
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 28, 2020 |  Series A - Bright Peak Therapeutics | 1 | - | 35.0M |
| Jun 10, 2021 | Series B - Bright Peak Therapeutics | 7 | - | 107.0M |
| Jun 11, 2024 | Series C - Bright Peak Therapeutics | 10 | - | 90.0M |
Recent Activity
There is no recent news or activity for this profile.